Average Co-Inventor Count = 5.80
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Visterra, Inc. (21 from 37 patents)
2. University of Massachusetts (12 from 1,551 patents)
3. Medarex Inc. (4 from 152 patents)
4. Centers for Disease Control and Prevention (2 from 26 patents)
5. The General Hospital Corporation (1 from 2,882 patents)
6. E. R. Squibb Sons, Inc. (1 from 1,624 patents)
33 patents:
1. 12415865 - Antibody molecules to C5AR1 and uses thereof
2. 12297249 - Interleukin-2 agents and uses thereof
3. 12264203 - Humanized complement 5a receptor 1 antibodies and methods of use thereof
4. 12227587 - Humanized complement 5A receptor 1 antibodies and methods of use thereof
5. 12187807 - Antibody molecules to C5AR1 and uses thereof
6. 12098178 - Methods of using interleukin-2 agents
7. 12091451 - Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)
8. 12084484 - Interleukin-2 agents and uses thereof
9. 12054539 - Antibody molecules to dengue virus and uses thereof
10. 11912781 - Humanized complement 5A receptor 1 antibodies and methods of use thereof
11. 11820979 - Binding polypeptides and methods of making the same
12. 11773179 - Antibody molecules to C5aR1 and uses thereof
13. 11136385 - Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule
14. 11059883 - Antibody molecules to dengue virus and uses thereof
15. 10981982 - Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)